Literature DB >> 7684729

Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein.

Y P Shi1, V Udhayakumar, M P Alpers, M M Povoa, A J Oloo, T K Ruebush, A A Lal.   

Abstract

Synthetic peptides and human serum or plasma samples from regions of Brazil, Papua New Guinea, and Kenya in which malaria is endemic were used to identify B-cell epitopes localized outside the repeat region of the circumsporozoite (CS) protein of the human malaria parasite Plasmodium falciparum. In agreement with recent observations, our results confirm the presence of two non-repeat-region-based B-cell epitopes of the CS protein. Of these two epitopes, only the region I epitope (KPKHKKLKQPGDGNP) was previously shown to be recognized by human sera. In this study, we show that human immune sera from malarious regions recognize another B-cell epitope, ENANANNAV, that resides carboxyl to the repeat region. The present study reveals that (i) the repeat-sequence (NANP)-based B-cell epitope of the CS protein is an immunogenic but not immunodominant epitope; (ii) the natural expression of antibody responses to the two non-repeat-region-based B-cell epitopes of the CS protein varies in different populations in which malaria is endemic; (iii) although the host immune responses to the non-repeat-region-based B-cell epitopes increase as a function of host age, this increase is not statistically significant for the region I epitope but is significant for the other epitope; and (iv) the Th1R T-cell site but not the Th2R or Th3R T-cell site induces an antibody response in the human host. This study confirms the immunogenic potential of non-repeat-region-based B-cell epitopes and suggests that antibody pressures may also contribute to the maintenance of the antigenic diversity of the CS protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684729      PMCID: PMC280865          DOI: 10.1128/iai.61.6.2425-2433.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Rationale for the development of an engineered sporozoite malaria vaccine.

Authors:  V Nussenzweig; R S Nussenzweig
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax.

Authors:  P Romero; E P Heimer; S Herrera; A M Felix; R S Nussenzweig; F Zavala
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

3.  Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum.

Authors:  S Kumar; L H Miller; I A Quakyi; D B Keister; R A Houghten; W L Maloy; B Moss; J A Berzofsky; M F Good
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

4.  Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon.

Authors:  C Chizzolini; A Dupont; J P Akue; M H Kaufmann; A S Verdini; A Pessi; G Del Giudice
Journal:  Am J Trop Med Hyg       Date:  1988-08       Impact factor: 2.345

5.  Differential antibody responses to Plasmodium falciparum and P. vivax circumsporozoite proteins in a human population.

Authors:  T R Burkot; P M Graves; R A Wirtz; B J Brabin; D Battistutta; J A Cattani; R M Maizels; M P Alpers
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

6.  Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.

Authors:  H M Etlinger; A M Felix; D Gillessen; E P Heimer; M Just; J R Pink; F Sinigaglia; D Stürchler; B Takacs; A Trzeciak
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

7.  Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.

Authors:  G Del Giudice; Q Cheng; D Mazier; N Berbiguier; J A Cooper; H D Engers; C Chizzolini; A S Verdini; F Bonelli; A Pessi
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

8.  Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

Authors:  M F Good; W L Maloy; M N Lunde; H Margalit; J L Cornette; G L Smith; B Moss; L H Miller; J A Berzofsky
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

9.  Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Authors:  G Del Giudice; H D Engers; C Tougne; S S Biro; N Weiss; A S Verdini; A Pessi; A A Degremont; T A Freyvogel; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

10.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.

Authors:  D A Herrington; D F Clyde; G Losonsky; M Cortesia; J R Murphy; J Davis; S Baqar; A M Felix; E P Heimer; D Gillessen
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

View more
  12 in total

1.  Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.

Authors:  Kathrin Kastenmüller; Diego A Espinosa; Lauren Trager; Cristina Stoyanov; Andres M Salazar; Santosh Pokalwar; Sanjay Singh; Sheetij Dutta; Christian F Ockenhouse; Fidel Zavala; Robert A Seder
Journal:  Infect Immun       Date:  2012-12-28       Impact factor: 3.441

2.  High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.

Authors:  Thomas Jaenisch; Kirsten Heiss; Nico Fischer; Carolin Geiger; F Ralf Bischoff; Gerhard Moldenhauer; Leszek Rychlewski; Ali Sié; Boubacar Coulibaly; Peter H Seeberger; Lucjan S Wyrwicz; Frank Breitling; Felix F Loeffler
Journal:  Mol Cell Proteomics       Date:  2019-01-10       Impact factor: 5.911

3.  A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.

Authors:  Anjali Yadava; Jetsumon Sattabongkot; Michael A Washington; Lisa A Ware; Victoria Majam; Hong Zheng; Sanjai Kumar; Christian F Ockenhouse
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

4.  Multiple antigen peptide vaccines against Plasmodium falciparum malaria.

Authors:  Babita Mahajan; Jay A Berzofsky; Robert A Boykins; Victoria Majam; Hong Zheng; Rana Chattopadhyay; Patricia de la Vega; J Kathleen Moch; J David Haynes; Igor M Belyakov; Hira L Nakhasi; Sanjai Kumar
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

5.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.

Authors:  R B Lal; D Rudolph; M P Alpers; A J Sulzer; Y P Shi; A A Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

7.  Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

Authors:  Ally Olotu; Frederic Clement; Erik Jongert; Johan Vekemans; Patricia Njuguna; Francis M Ndungu; Kevin Marsh; Geert Leroux-Roels; Philip Bejon
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

8.  High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical Malaria.

Authors:  Vittoria Offeddu; Ally Olotu; Faith Osier; Kevin Marsh; Kai Matuschewski; Vandana Thathy
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

9.  Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.

Authors:  Mohammad Zeeshan; Mohammad Tauqeer Alam; Sumiti Vinayak; Hema Bora; Rupesh Kumar Tyagi; Mohd Shoeb Alam; Vandana Choudhary; Pooja Mittra; Vanshika Lumb; Praveen Kumar Bharti; Venkatachalam Udhayakumar; Neeru Singh; Vidhan Jain; Pushpendra Pal Singh; Yagya Dutta Sharma
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections.

Authors:  Angela M Early; Marc Lievens; Bronwyn L MacInnis; Christian F Ockenhouse; Sarah K Volkman; Samuel Adjei; Tsiri Agbenyega; Daniel Ansong; Stacey Gondi; Brian Greenwood; Mary Hamel; Chris Odero; Kephas Otieno; Walter Otieno; Seth Owusu-Agyei; Kwaku Poku Asante; Hermann Sorgho; Lucas Tina; Halidou Tinto; Innocent Valea; Dyann F Wirth; Daniel E Neafsey
Journal:  Nat Commun       Date:  2018-04-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.